Holen Sie sich die Stockscreener-App
10.29
3.21%
0.32
Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
26.08%
56.50
|
44.81 | 75.45 | 54.48 | 52.44 |
| Cost Of Revenue |
19.68%
12.47
|
10.42 | 23.13 | 12.17 | 12.30 |
| Selling, General, and Administrative |
4.75%
17.55
|
18.42 | - | - | - |
| Costs And Expenses |
0.57%
48.92
|
48.64 | 58.35 | 44.90 | 45.80 |
| Depreciation and Amortization |
2.63%
2.516
|
2.584 | 2.657 | 2.722 | 2.763 |
| Operating Income/Loss |
298.15%
7.585
|
-3.828 | 17.11 | 9.573 | 6.636 |
| Nonoperating Income/Loss |
64.59%
0.66
|
0.401 | 0.001 | -0.33 | -0.471 |
| Income/Loss From Continuing Operations Before Tax |
340.59%
8.245
|
-3.427 | 17.11 | 9.243 | 6.165 |
| Income Tax Expense/Benefit, Current |
82.82%
0.056
|
0.326 | 0.424 | 0.399 | 0.31 |
| Net Income/Loss |
318.20%
8.189
|
-3.753 | 13.44 | 8.844 | 5.855 |
| Basic Average Shares |
0.19%
50.94
|
50.85 | 0.1303 | 50.34 | 49.70 |
| Diluted Average Shares |
3.44%
52.60
|
50.85 | 0.3187 | 50.93 | 50.14 |
| Basic Earnings Per Share |
328.57%
0.16
|
-0.07 | 0.27 | 0.18 | 0.12 |
| Diluted Earnings Per Share |
328.57%
0.16
|
-0.07 | 0.26 | 0.17 | 0.12 |
1.64%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):